Meticulous Research®—leading global market research company published a research report titled, ‘Pharmaceutical Automation Market by Component (Plant-level Controls, Enterprise-level Controls, Plant Instrumentation), Mode of Automation (Semi-automatic, Fully-automatic), End User and Geography - Global Forecast to 2029.’
The pharmaceutical automation market is projected to reach $18.2 billion by 2029 at a CAGR of 12% from 2022 to 2029. The growth of this market is attributed to the increasing adoption of robots in pharmaceutical manufacturing, government initiatives to promote industrial development, rising investments in transforming conventional production facilities, and growing demand for safe and digitized production processes. The growing demand for IIoT in pharmaceutical manufacturing and the huge demand for vaccine manufacturing for COVID-19 are expected to offer significant opportunities for the growth of this market.
However, the high initial investment to procure automation hardware and software is expected to hinder the growth of this market to a notable extent. Additionally, the limited availability of skilled laborers and cybersecurity risks associated with automated systems are major challenges for the growth of this market.
The pharmaceutical automation market is segmented based on component (enterprise-level controls [product lifecycle management, enterprise resource planning, manufacturing execution systems], plant instrumentation [motors & drives, robots, sensors, machine vision systems, relays & switches, and other plant instrumentation components], plant-level controls [supervisory control and data acquisition, distributed control systems, programmable logic controllers, other plant-level controls]), mode of automation (semi-automatic, fully-automatic), end user (pharmaceutical industry, biotech industry), and geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Based on component, the pharmaceutical automation market is segmented into enterprise-level controls, plant instrumentation, and plant-level controls. In 2022, the enterprise-level controls segment is estimated to account for the largest share of the pharmaceutical automation market. The large market share of this segment is attributed to the benefits of implementing product lifecycle management, enterprise resource planning, and manufacturing execution systems solutions at the enterprise level. Manufacturing execution systems solutions integrated with process control systems enable pharmaceutical manufacturers to increase productivity and efficiency at a lower cost and significantly reduce the time-to-market of new products. Furthermore, these systems enable organizations to maintain and manage records of their lifecycle, resulting in cost savings.
Based on mode of automation, the pharmaceutical automation market is segmented into semi-automatic and fully-automatic systems. In 2022, the semi-automatic segment is expected to account for the larger share of the pharmaceutical automation market. Semi-automatic systems involve both manual and machine-aided assemblies. These systems are the broadest part of the assembly and require a human operator both at the start and the end of the process. Semi-automatic systems require help from a human operator for loading and unloading the entire system. Semi-automatic systems are beneficial for companies that emphasize improving their manufacturing process but hesitate or cannot eliminate operator assistance.
Based on the end user, the pharmaceutical automation market is segmented into pharmaceutical industry and biotech industry. In 2022, the pharmaceutical industry segment is expected to account for the largest share of the pharmaceutical automation market. The large market share of this segment is attributed to the rapid adoption of continuous improvement process (CIP) to improve production flexibility and efficiency and reduce wastage. Furthermore, prominent technology players such as Microsoft, IBM, and Google are engaged in developing automation and cloud solutions for the pharmaceutical and healthcare industry to close security gaps and protect healthcare and pharmaceutical production networks from external attacks.
This research report analyzes major geographies and provides a comprehensive analysis of North America (U.S. and Canada), Europe (U.K., Germany, France, Italy, Spain, Netherlands, Sweden, and the rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Singapore, and the rest of Asia-Pacific), Latin America (Brazil, Mexico, and the rest of Latin America), and the Middle East & Africa (UAE, Saudi Arabia, South Africa, and the rest of the Middle East & Africa).
In 2022, Asia-Pacific is expected to account for the largest share of the pharmaceutical automation market, followed by Europe and North America. Asia-Pacific’s large market share is attributed to high technical awareness regarding the usage of robotics in China, Japan, and Singapore. The Asian pharmaceutical manufacturing sector has robust production capabilities, which further fuels the demand for pharmaceutical automation solutions in Asia-Pacific. For instance, Thailand’s Mahidol University and the Institute of Molecular Biosciences used ABB YuMi cobot and an industrial robot that functions as part of the AI-Immunizer system to handle samples of viruses as well as antibodies. These robots can perform tasks such as unscrewing vials, transporting them to test stations, and performing repetitive actions to minimize risks to human operators.
The key players operating in the pharmaceutical automation market include ABB Group (Switzerland), Rockwell Automation (U.S.), Siemens AG (Germany), Yaskawa Electric Corporation (Japan), Schneider Electric (France), Yokogawa Electric Corporation (Japan), KUKA AG (Germany), Emerson Electric (U.S.), Fanuc (Japan), Honeywell International (U.S.), Mitsubishi Electric Corporation (Japan), OMRON Corporation (Japan), Advantech Co., Ltd. (Taiwan), and Fuji Electric Co., Ltd. (Japan).
Download Free Sample PDF Copy Here: https://www.meticulousresearch.com/download-sample-report/cp_id=5280
Key Questions Answered in the Report:
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research